Lawyers and Settlements
Home Page >> Lawsuits Filed >> Lawsuit: Taxotere Hair Loss Lawsuit Filed

Taxotere Hair Loss Lawsuit Filed

Were you looking for Taxotere Permanent Hair Loss lawsuits?

Santa Clara, CA: Sanofi-Aventis is facing a defective product lawsuit alleging its cancer drug Taxotere (Docetaxel) causes hair loss. Filed by Erma Spann, the lawsuit claims Sanofi withheld important information from patients about the potential long-term side effects of Taxotere.


Send your Taxotere Hair Loss claim to a lawyer who will review your claim at NO COST or obligation.Get Legal Help Now

Taxotere Hair Loss Lawsuit

Spann alleges she has experienced on-going and permanent hair loss after undergoing chemotherapy involving Taxotere following a right breast partial mastectomy in February 2005.

Spann further alleges that Sanofi-Aventis knew or should have known that, unlike other cancer drugs, Taxotere had a high risk of permanent baldness, known as alopecia. She asserts that rather than issuing warnings regarding the potential for hair loss Sanofi concealed the information, depriving her and other patients of the opportunity to decide whether the risk of permanent baldness was justified.

"Although women might accept the possibility of permanent baldness as a result of the use of Taxotere if no other product were available to treat their cancer, this was not the case,"Spann states in the complaint. "Before Defendants' wrongful conduct resulted in thousands of women being exposed to the side effects of Taxotere, there were already similar products on the market that were at least as effective as Taxotere and did not subject female users to the same risk of disfiguring permanent alopecia as does Taxotere."

The lawsuit cites a study published in 2005, known as GEICAM 9805, that found nearly 10% of patients who took Taxotere suffered permanent hair loss. The manufacturers were aware of that study and of observations by a Denver-based oncologist in 2006, which found that more than 6% of his Taxotere patients suffered permanent hair loss.

"Despite Defendants' knowledge of the relevant findings from the GEICAM 9805 study, as well as reports from patients who had taken Taxotere and suffered from permanent disfiguring hair loss, Defendants failed to provide accurate information and proper warnings to physicians, healthcare providers, and patients in the United States, including Plaintiff, that patients who take Taxotere are at a significantly increased risk of suffering from permanent disfiguring hair loss,"the lawsuit states. "Instead, Defendants chose to withhold this information in the United States despite advising physicians, patients, and regulatory agencies in other countries, including the European Union and Canada, that Taxotere causes an increased risk of permanent disfiguring hair loss."

According to the lawsuit, Taxotere warnings continue to vaguely and misleadingly indicate that "hair generally grows back"after use of the drug.

Taxotere Hair Loss Legal Help

If you or a loved one has suffered similar damages or injuries, please click the link below and your complaint will be sent to a lawyer who may evaluate your claim at no cost or obligation.
Last updated on


Pharmaceuticals Fast-Tracked to Market through Little-Known FDA Protocol
Pharmaceuticals Fast-Tracked to Market through Little-Known FDA Protocol New Orleans, LA: An interesting sidebar to Taxotere hair loss litigation has opened up through a peek into docetaxel hair loss multidistrict litigation, and an accompanying analysis of the various approval protocols employed to bring both branded and generic docetaxel (Taxotere) to the market [READ MORE]

Science Day Scheduled For Taxotere Multidistrict Litigation
Science Day Scheduled For Taxotere Multidistrict Litigation New Orleans, LA A multidistrict litigation of hundreds of Taxotere lawsuits alleging that the chemotherapy drug Taxotere causes permanent hair loss continues to move forward in federal court with a "Science Day" scheduled in May [READ MORE]

California Women Suffers Permanent Hair Loss after Taxotere Chemo – Suit Claims
California Women Suffers Permanent Hair Loss after Taxotere Chemo – Suit Claims San Francisco, CA In 2010, Ami Dodson was diagnosed with stage two breast cancer and underwent a partial mastectomy to remove the cancer. Her oncologists suggested they follow up with chemotherapy treatments using a drug known as Taxotere. Her prognosis was excellent and there was every expectation she would live a normal life [READ MORE]


Fields marked * are mandatory. Please read our comment guidelines before posting.


Note: Your name will be published with your comment.

*Email Address:

Your email will only be used if a response is needed.

*Your Comment:

Are you the defendant or a subject matter expert on this topic with an opposing viewpoint? We'd love to hear your comments here as well, or if you'd like to contact us for an interview please submit your details here.

Request Taxotere Hair Loss Legal Help

First name:

Last name:

Email address:

Phone number(s):

Zip/Postal Code:

Describe your complaint:

By submitting this form I agree to the Terms of Service.
There is no cost to submit this form.
I would like to be interviewed by a journalist.
Receive our weekly newsletter with the latest lawsuit news and legal information.

Check Claim Status Advertise with us Legal Funding

Related Lawsuits

Legal Services:

FAQ | TOS | Privacy | Disclaimer | About Us | Contact Us | Press | Advertise | Member Login | Site Map | View Mobile Website

American Bar Association - Proud Member   Better Business Bureau   CAALA   Best of the Web Approved   Public Justice

This work is licensed under a Creative Commons Attribution-NoDerivs 3.0 Unported License © 2001-2017 Online Legal Media. All rights reserved.

Visit other Online Legal Media Websites: